Hemodynamic-Guided Therapy is Associated with Better Hypertension Control Compared with Standard Care: A Comparative Clinical Analysis
Why the study?
Blood pressure abnormalities are common in patients with heart-related conditions and substantially increase morbidity and mortality, prompting evaluation of hemodynamic-guided therapy compared with standard care.
Does hemodynamic-guided therapy improve systolic and diastolic blood pressure in patients with cardiovascular disease compared with standard care?
Population
156 patients with cardiovascular disease
Comparison
Hemodynamic-guided therapy vs standard care
Design
Retrospective comparative study
Key result
Hemodynamic-guided therapy significantly reduced systolic blood pressure to 132.11 mmHg compared to 153.18 mmHg with standard care in patients with hypertension and cardiovascular comorbidities.
Authors
Loading...
HGT may improve BP control versus standard care in CVD; hypothesis-generating and requires RCTs before practice change.
Cohort (n=156)
No
Does hemodynamic-guided therapy improve systolic and diastolic blood pressure in patients with cardiovascular disease compared with standard care?
Hemodynamic-guided therapy using noninvasive monitoring to titrate medications may significantly improve blood pressure control in patients with cardiovascular disease compared to standard care.
Absolute Event Rate: 132.11% vs 153.18%
p-value: p=<0.001
Nassef et al. (2026) conducted a cohort in Hypertension and cardiovascular disease (n=156). Hemodynamic-Guided Therapy (HGT) vs. Standard care was evaluated on Post-treatment systolic blood pressure (mmHg) (p=<0.001). Hemodynamic-guided therapy significantly reduced systolic blood pressure to 132.11 mmHg compared to 153.18 mmHg with standard care in patients with hypertension and cardiovascular comorbidities.